Paradi Mirmirani
Overview
Explore the profile of Paradi Mirmirani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
672
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akiska Y, Mirmirani P, Roseborough I, Mathes E, Bhutani T, Ambrosy A, et al.
JAMA Dermatol
. 2024 Nov;
161(1):87-95.
PMID: 39565602
Importance: The results of small studies suggest that off-label use of low-dose oral minoxidil (LDOM) may be safe and effective for patients with hair loss, but larger trials and standardized...
2.
Piliang M, Lynde C, King B, Mirmirani P, Sinclair R, Senna M, et al.
J Am Acad Dermatol
. 2024 Oct;
92(2):276-284.
PMID: 39423930
Background: Few treatments for alopecia areata have demonstrated sustained efficacy. Objective: Evaluate the efficacy and safety of continued ritlecitinib treatment to week 48 in patients with alopecia areata with or...
3.
Chang C, Ticknor I, Spinelli J, Bhatia B, Marwaha S, Mirmirani P, et al.
JAAD Int
. 2024 Apr;
15:152-154.
PMID: 38571697
No abstract available.
4.
Moussa A, Bennett M, Wall D, Meah N, York K, Bokhari L, et al.
JAMA Dermatol
. 2024 Feb;
160(3):341-350.
PMID: 38324292
Importance: Current measures of alopecia areata (AA) severity, such as the Severity of Alopecia Tool score, do not adequately capture overall disease impact. Objective: To explore factors associated with AA...
5.
Mirmirani P, Young P, Vanderweil S, Vanchinathan V, Click J, McCleskey P
Dermatol Online J
. 2023 Nov;
29(4).
PMID: 37921823
No abstract available.
6.
Karim N, Mirmirani P, Durbin-Johnson B, Rocke D, Salemi M, Phinney B, et al.
PLoS One
. 2023 Mar;
18(3):e0283619.
PMID: 37000833
Protein profiling offers an effective approach to characterizing how far epidermis departs from normal in disease states. The present pilot investigation tested the hypothesis that protein expression in epidermal corneocytes...
7.
Pathoulas J, Flanagan K, Walker C, Collins M, Ali S, Pupo Wiss I, et al.
J Am Acad Dermatol
. 2022 Nov;
88(4):937-939.
PMID: 36396001
No abstract available.
8.
Samrao A, Mirmirani P
Skin Appendage Disord
. 2022 Aug;
8(4):328-332.
PMID: 35983466
Introduction: Telogen effluvium (TE) is a type of diffuse hair shedding that occurs 2-3 months after an exposure or trigger. The excessive hair loss may "unmask" underlying hair loss disorders...
9.
King B, Mesinkovska N, Mirmirani P, Bruce S, Kempers S, Guttman-Yassky E, et al.
J Am Acad Dermatol
. 2022 Apr;
87(2):306-313.
PMID: 35364216
Background: Janus kinase (JAK) activation is suggested to have a pathological role in alopecia areata (AA). CTP-543, a deuterated compound that selectively inhibits JAK1 and JAK2, is being developed as...
10.
King B, Atanaskova Mesinkovska N, Craiglow B, Kindred C, Ko J, McMichael A, et al.
J Am Acad Dermatol
. 2021 Sep;
86(2):359-364.
PMID: 34474079
Background: The current classification for alopecia areata (AA) does not provide a consistent assessment of disease severity. Objective: To develop an AA severity scale based on expert experience. Methods: A...